PT Pabrik Kertas Tjiwi Kimia Tbk (IDX:TKIM)

Sage Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	221.54	194.48	187.8	205.04	205.56	161.73
Short-Term Investments	-	190.82	213.25	213.35	194.06	274.07
Trading Asset Securities	-	19.31	19.16	17.78	18.6	17.79
Cash & Short-Term Investments	221.54	404.61	420.21	436.17	418.21	453.59
Cash Growth	-46.07%	-3.71%	-3.66%	4.29%	-7.80%	-1.41%
Accounts Receivable	79.51	110.37	71.32	97.39	47.86	69.12
Other Receivables	0.47	0.46	1.38	0.34	0.54	0.35
Receivables	79.98	110.82	72.7	97.73	48.4	69.47
Inventory	270.5	253.94	218.06	283.99	282.37	261.81
Prepaid Expenses	-	5.04	21.37	12.61	5.95	13.13
Other Current Assets	250.47	17.15	17.16	20.26	50.41	39.05
Total Current Assets	822.49	791.57	749.49	850.76	805.33	837.04
Property, Plant & Equipment	839.19	841.46	858.28	847.71	880.46	930.83
Long-Term Investments	2,263	2,185	1,945	1,779	1,392	1,172
Long-Term Deferred Tax Assets	-	-	0.18	0.94	1.53	1.18
Other Long-Term Assets	28.52	38.02	57.11	66.7	82.25	132.61
Total Assets	3,954	3,856	3,610	3,545	3,162	3,073
Accounts Payable	251.34	203.33	122.21	188.09	143.15	129.86
Accrued Expenses	8.25	14.64	16.87	18.01	25.63	19.76
Short-Term Debt	253.22	289.97	348.62	378.64	404.49	350.19
Current Portion of Long-Term Debt	41.6	72.29	74.72	74.94	67.42	72.39
Current Portion of Leases	33.21	0.04	0.04	0.78	4.36	4.01
Current Income Taxes Payable	3.13	2.14	7.24	2.51	4.26	3.42
Other Current Liabilities	33.66	21.62	37	31.33	28.26	25.89
Total Current Liabilities	624.41	604.03	606.69	694.31	677.56	605.51
Long-Term Debt	497.94	514.46	561.14	576.58	656.68	868.71
Long-Term Leases	0.14	0.15	0.01	0.02	0.72	5.47
Long-Term Deferred Tax Liabilities	27.63	27.42	28.71	28.98	33.02	29.7
Other Long-Term Liabilities	9.2	9.68	6.61	7.05	13.58	13.61
Total Liabilities	1,181	1,177	1,224	1,327	1,403	1,561
Common Stock	684.81	684.81	684.81	684.81	684.81	684.81
Additional Paid-In Capital	29.22	29.22	29.22	29.22	29.22	29.22
Retained Earnings	2,064	1,970	1,678	1,511	1,053	806.74
Comprehensive Income & Other	-5.01	-5.27	-6.14	-6.32	-8.63	-8.29
Total Common Equity	2,773	2,679	2,386	2,219	1,758	1,512
Shareholders' Equity	2,773	2,679	2,386	2,219	1,758	1,512
Total Liabilities & Equity	3,954	3,856	3,610	3,545	3,162	3,073
Total Debt	826.11	876.91	984.53	1,031	1,134	1,301
Net Cash (Debt)	-604.57	-472.3	-564.32	-594.79	-715.46	-847.18
Net Cash Per Share	-0.19	-0.15	-0.18	-0.19	-0.23	-0.27
Filing Date Shares Outstanding	3,113	3,113	3,113	3,113	3,113	3,113
Total Common Shares Outstanding	3,113	3,113	3,113	3,113	3,113	3,113
Working Capital	198.08	187.54	142.8	156.46	127.77	231.53
Book Value Per Share	0.89	0.86	0.77	0.71	0.56	0.49
Tangible Book Value	2,773	2,679	2,386	2,219	1,758	1,512
Tangible Book Value Per Share	0.89	0.86	0.77	0.71	0.56	0.49
Land	-	37.96	37.95	37.85	37.73	37.73
Buildings	-	235.72	235.23	234.2	234.02	229.74
Machinery	-	2,629	2,565	2,544	2,527	2,514
Construction In Progress	-	78.63	138.9	81.89	45.55	31

Updated Oct 31, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.